ÂÜÀòÂÒÂ×

Danny Spiegelstein MD, is UltraSight’s vice president of product development. Dr. Spiegelstein has 20+ years of medical experience in cardiovascular invasive medicine. He is an experienced clinical research investigator, managing protocols and operations in compliance with GMP and other regulatory requirements. Prior to UltraSight, Dr. Spiegelstein served as a consultant for medical start-ups in cardiology.